In the era of precision medicine, every cancer will be treated in a personalized way according to molecular testing of the cancer. The traditional blanket chemotherapy is unpredictable and has tremendous side effects on the patient. The emergence of immunotherapy, targeted therapy and hormone therapy improves patient outcome both in terms of overall survival and overall cost.
To initiate an immunotherapy or targeted therapy every cancer patient should undergo molecular biomarker testing. TMSS Bio-molecular Laboratory enables us to do the biomarker testing and treat the patient in a personalized way.
Molecular biomarker testing is essential for identifying which cancer patients will benefit from immunotherapy, targeted therapy, or hormone therapy. Research demonstrates that when treatment is matched to a patient's specific tumor biomarkers, overall survival improves significantly—by up to 7 months in many cancer types—while reducing unnecessary treatment costs and side effects.
Clinical guidelines from leading cancer organizations worldwide recommend comprehensive biomarker testing for all cancer patients before initiating immunotherapy or targeted therapies. This testing identifies specific genetic changes in your tumor that can be targeted with personalized medicines, offering better outcomes than traditional one-size-fits-all approaches.
TMSS Biomolecular Laboratory performs comprehensive biomarker testing using internationally validated methods, while TMSS Cancer Care Center ensures that test results translate into personalized, evidence-based treatment plans tailored to each patient's unique cancer profile.
Advanced NGS platforms with bioinformatics pipeline meeting international standards. Detects multiple cancer-driving biomarkers in a single comprehensive test.
Rigorous quality controls at every step. Internationally trained personnel, validated methods, and strict protocols for patient safety and confidentiality.
Highest ethical standards in laboratory medicine — confidentiality, transparent communication, and impartial testing with comprehensive staff competency programs.
Every test is carefully selected and validated to provide clinically meaningful information. We participate in external proficiency programs to independently verify accuracy.
Biomarker testing examines the genetic makeup of your cancer cells to identify specific changes (mutations) that can be targeted with personalized medications. Molecular testing helps us understand exactly what type of cancer you have so your doctor can choose the most effective treatment for you.
Traditional chemotherapy affects both cancer cells and healthy cells, causing significant side effects. Targeted therapies specifically attack cancer cells with certain genetic changes while sparing healthy tissue — often meaning better results with fewer side effects.
Your doctor will send a small sample of your tumor tissue to our laboratory. Our advanced technology analyzes the genetic information in the cancer cells to identify treatable biomarkers. We deliver comprehensive reports to your oncologist, typically within two weeks.
At TMSS Biomolecular Lab, we understand that behind every sample is a person, a family, and a story. Our ISO 15189-compliant quality management system ensures that every test we perform meets the highest international standards for accuracy and reliability.
We are committed to supporting Bangladesh's oncology community with locally available, affordable, and world-class molecular diagnostics that make precision cancer medicine a reality for all patients.
We maintain accuracy by using state-of-the-art technology equipment for testing.
We maintain ethical and good professional practices.
We provide testing facilities that are fit for intended use.
We are in compliance with the requirements of ISO 15189 & other relevant regulatory requirements for continual improvement of the quality of laboratory services.